Key Record Dates
ClinicalTrials.gov Identifier: | NCT05555732 |
---|---|
Brief Title: | Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) |
First Submitted : | September 22, 2022 |
First Submitted that Met QC Criteria : | September 22, 2022 |
First Posted : | September 27, 2022 |
Last Update Submitted that Met QC Criteria : | April 10, 2024 |
Last Update Posted : | April 11, 2024 |